MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2025)
MapLight Therapeutics (MPLT) posted Net Equity Issued and Repurchased of $200.0 million for Q4 2025, little changed sequentially from $200.0 million in Q3 2025.
Powered by 
Analysis
MapLight Therapeutics (MPLT) Net Equity Issued and Repurchased (2025) Analysis & Trends
MapLight Therapeutics has reported Net Equity Issued and Repurchased for 1 years, with the latest figure at $200.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | MapLight Therapeutics | 635.58 Mn | 635.58 Mn | - | - |